$INSM (INSMED) — 8-K: INSM Q2 FY26: GAAP EPS of -$0.06 crushes consensus by 91.2%.
INSM
$129.41
+1.67%
What changed
Insmed posted a GAAP EPS of -$0.06, beating the -$0.68 consensus by $0.62 (+91.2%). Revenue surged 296.1% YoY to $426M. The company issued FY2026 revenue guidance of $1.2B-$1.4B.
Why it matters
Insmed posted a GAAP EPS of -$0.06, beating the -$0.68 consensus by $0.62 (+91.2%). Revenue surged 296.1% YoY to $426M. The company issued FY2026 revenue guidance of $1.2B-$1.4B.